Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Other Working Capital Changes (2017 - 2025)

Selectis Health's Other Working Capital Changes history spans 14 years, with the latest figure at -$56990.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 198.36% year-over-year to -$56990.0; the TTM value through Sep 2025 reached -$299789.0, down 113.56%, while the annual FY2024 figure was -$1.0 million, 150.01% down from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$56990.0 at Selectis Health, up from -$179354.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.8 million in Q4 2023 and bottomed at -$515097.0 in Q2 2021.
  • The 5-year median for Other Working Capital Changes is -$179354.0 (2025), against an average of -$30938.5.
  • The largest YoY upside for Other Working Capital Changes was 2605.58% in 2021 against a maximum downside of 4709.94% in 2021.
  • A 5-year view of Other Working Capital Changes shows it stood at $161084.0 in 2021, then crashed by 342.42% to -$390501.0 in 2022, then skyrocketed by 816.93% to $2.8 million in 2023, then crashed by 114.69% to -$411196.0 in 2024, then soared by 86.14% to -$56990.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Other Working Capital Changes are -$56990.0 (Q3 2025), -$179354.0 (Q2 2025), and $347751.0 (Q1 2025).